Delivery Order SPE2DB20D7059-SPE2DB24FPYR9
Award Date 2/5/24
Potential Completion Date 2/6/24
Potential Value $2.8K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,511.18, is for the delivery of GLATIRAMER 40 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has an ultimate completion date of March 11, 2025 and is a Firm Fixed Price Delivery Order. The contract was not designated with a set-aside requirement, indicating open...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,911.09 firm fixed-price delivery order is for the supply of GLATIRAMER 40 MG/ML SYRINGEML, a medication, with an ultimate completion date of March 27, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,158.51 firm fixed-price delivery order is for the supply of GLATIRAMER 40 MG/ML SYRINGE, a specialty medication. The contract has an ultimate completion date of March 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,832.12 Firm Fixed Price delivery order is for the supply of 4560559530 units of glatiramer 40 mg/ml syringes, with a performance period ending on April 12, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,554.09, is for the supply of glatiramer 40 mg/ml syringes. The contract is a firm fixed-price, delivery order type with a completion date of February 11, 2025. No set-aside designation was used for this award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency awarded a $6,973.17 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Glatiramer 40 mg/ml syringes, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,834.96 firm-fixed-price delivery order is for the supply of 4565006756 GLATIRAMER 40 MG/ML SYRINGEML, a medical product, with a completion date of June 27, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $2,930.01 and has a performance period through March 2025. The contract is for the supply of Glatiramer 40 mg/mL syringes, a medication used for the treatment of multiple sclerosis. The contract was awarded on an unrestricted basis, with no set-aside designation. Amerisourcebergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,088.20 firm fixed-price delivery order contract is for the supply of GLATIRAMER 40 MG/ML SYRINGE medication, with a period of performance through July 11, 2023. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
- This federal contract award is for the delivery of GLATIRAMER 40 MG/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price of $10,837.26 and a period of performance through February 6, 2024. This award does not have a set-aside designation, indicating it was competed...